Jasper Therapeutics, Inc.
JSPRHealthcare|Biotechnology|US
$16.86
+2.78 (+19.78%)
DCF Value
$34.77
Tangible Book / Share
$1.48
Cash / Share
$7.65
Ownership Breakdown
89.6%
Float
1.1M
Shares Outstanding
1.0M
Float Shares
Major Holders (40)
Combined: 178.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Soleus GP LLC | Other | 9.96% | 1,494,420 | Feb 11, 2025 | 13D/G |
| Velan Capital Investment Management LP | Partnership | 9.90% | 3,363,347 | Aug 17, 2026 | 13D/G |
| Velan Capital Management LLC | Other | 9.90% | 3,363,347 | Aug 17, 2026 | 13D/G |
| Morgan Adam | Individual | 9.90% | 3,363,347 | Aug 17, 2026 | 13D/G |
| Venkataraman Balaji | Individual | 9.90% | 3,363,347 | Aug 17, 2026 | 13D/G |
| Velan Capital Holdings LLC | Other | 8.90% | 3,037,776 | Aug 17, 2026 | 13D/G |
| Velan Capital Master Fund LP | Partnership | 8.90% | 3,037,776 | Aug 17, 2026 | 13D/G |
| T. Rowe Price Investment Management, Inc. | Investment adviser | 7.10% | 2,057,612 | Nov 14, 2025 | 13D/G |
| Bank of America Corp /De/ | Holding company | 6.40% | 2,133,861 | Oct 28, 2026 | 13D/G |
| Anders Hove | Individual | 5.30% | 1,486,492 | Jan 26, 2026 | 13D/G |
| Morgan Stanley | HC, CO | 4.80% | 1,333,420 | May 12, 2026 | 13D/G |
| Kingdon Capital Management, L.L.C. | Investment adviser | 4.70% | 1,324,845 | Nov 12, 2025 | 13D/G |
| Mark Kingdon | HC, IN | 4.70% | 1,324,845 | Nov 12, 2025 | 13D/G |
| Morgan Stanley Capital Services LLC | BD, CO | 4.60% | 1,294,420 | May 12, 2026 | 13D/G |
| CG Subsidiary Holdings L.L.C. | Other | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Abingworth Bioventures VII LP | Partnership | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Abingworth LLP | Partnership | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Carlyle Genesis UK LLC | Other | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Carlyle Investment Management L.L.C. | Other | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| TC Group, L.L.C. | Other | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Carlyle Holdings I L.P. | Partnership | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Carlyle Holdings I GP Sub L.L.C. | Other | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Carlyle Holdings I GP Inc. | Corporation | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| The Carlyle Group Inc. | Corporation | 3.80% | 1,088,310 | Feb 18, 2026 | 13D/G |
| Gary E Rieschel | Individual | 3.30% | 928,964 | Nov 14, 2025 | 13D/G |
| Mark McDade | Individual | 3.30% | 928,964 | Nov 14, 2025 | 13D/G |
| Qiming U.S. Healthcare GP II, LLC | Other | 3.30% | 928,964 | Nov 14, 2025 | 13D/G |
| Qiming U.S. Healthcare Fund II, L.P. | Partnership | 3.30% | 928,964 | Nov 14, 2025 | 13D/G |
| Acorn Capital Advisors GP 2, LLC | Other | 3.10% | 862,166 | Jan 26, 2026 | 13D/G |
| Acorn Bioventures 2, L.P. | Partnership | 3.10% | 862,166 | Jan 26, 2026 | 13D/G |
| Acorn Bioventures, L.P. | Partnership | 2.20% | 624,326 | Jan 26, 2026 | 13D/G |
| Acorn Capital Advisors GP, LLC | Other | 2.20% | 624,326 | Jan 26, 2026 | 13D/G |
| Millennium Management LLC | Other | 1.70% | 486,933 | Jul 10, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 1.70% | 486,933 | Jul 10, 2026 | 13D/G |
| Israel A. Englander | Individual | 1.70% | 486,933 | Jul 10, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 1.70% | 486,454 | Jul 10, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 1.50% | 225,605 | Jul 17, 2025 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 1.00% | 276,312 | May 8, 2026 | 13D/G |
| Soleus GP, LLC | Other | 1.00% | 276,312 | May 8, 2026 | 13D/G |
| Guy Levy | Individual | 1.00% | 276,312 | May 8, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,773,269 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| WIGGANS THOMAS G | director | Jul 31, 2026 | AWARD | 7,500 | $0.63 | $4.7K | Form 4 |
| Lucas Svetlana | director | Jul 31, 2026 | AWARD | 7,500 | $0.63 | $4.7K | Form 4 |
| Crutcher Patrick J | director | Jul 31, 2026 | AWARD | 7,500 | $0.63 | $4.7K | Form 4 |
| EMSTER KURT VON | director | Jul 31, 2026 | AWARD | 7,500 | $0.63 | $4.7K | Form 4 |
| Shizuru Judith Anne | director | Jul 31, 2026 | AWARD | 7,500 | $0.63 | $4.7K | Form 4 |
| Keenan Greg | Chief Medical Officer | Jul 16, 2026 | OTHER | 103,204 | $0.01 | $1.0K | Form 4 |
| Keenan Greg | Chief Medical Officer | Jul 16, 2026 | OTHER | 92,278 | $0.61 | $56.3K | Form 4 |
| Ros Matthew E | Chief Operating Officer | Jul 20, 2026 | BUY | 881 | — | — | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 0 | — | — | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 0 | — | — | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 630 | $2.72 | $1.7K | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 1,973 | $2.83 | $5.6K | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 5,885 | $3.59 | $21.1K | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 563 | $165.92 | $93.4K | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 1,764 | $172.63 | $304.5K | Form 4 |
| Song Wenru | EVP, Head of R&D | Jul 16, 2026 | OTHER | 5,262 | $218.99 | $1.2M | Form 4 |
| Ros Matthew E | Chief Operating Officer | Jul 16, 2026 | OTHER | 103,204 | $0.01 | $1.0K | Form 4 |
| Ros Matthew E | Chief Operating Officer | Jul 16, 2026 | OTHER | 92,278 | $0.61 | $56.3K | Form 4 |
| Crutcher Patrick J | director | Jul 16, 2026 | AWARD | 15,000 | $0.77 | $11.6K | Form 4 |
| Crutcher Patrick J | director | Jul 20, 2026 | BUY | 888 | — | — | Form 4 |
| Crutcher Patrick J | director | Jul 16, 2026 | OTHER | 0 | — | — | Form 4 |
| Crutcher Patrick J | director | Jul 16, 2026 | OTHER | 463,452 | — | — | Form 4 |
| Mahal Jeetinder Singh | director, officer: CEO and President | Feb 6, 2026 | AWARD | 500,000 | $1.35 | $675.0K | Form 4 |
| MARTELL RON | director, officer: President, CEO and Director | Jan 2, 2026 | AWARD | 234,000 | $1.84 | $430.6K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Jan 2, 2026 | AWARD | 90,000 | $1.84 | $165.6K | Form 4 |
| CROSS HERB | Chief Financial Officer | Jan 2, 2026 | AWARD | 90,000 | $1.84 | $165.6K | Form 4 |
| WIGGANS THOMAS G | director | Sep 22, 2025 | BUY | 41,000 | $2.43 | $99.6K | Form 4 |
| WIGGANS THOMAS G | director | Sep 22, 2025 | BUY | 41,000 | $2.92 | $119.7K | Form 4 |
| Lucas Svetlana | director | Sep 22, 2025 | BUY | 20,000 | $2.43 | $48.6K | Form 4 |
| Lucas Svetlana | director | Sep 22, 2025 | BUY | 20,000 | $2.92 | $58.4K | Form 4 |
| MARTELL RON | director, officer: President and CEO | Sep 22, 2025 | BUY | 41,000 | $2.43 | $99.6K | Form 4 |
| MARTELL RON | director, officer: President and CEO | Sep 22, 2025 | BUY | 41,000 | $2.92 | $119.7K | Form 4 |
| Shizuru Judith Anne | director | Sep 22, 2025 | BUY | 41,000 | $2.43 | $99.6K | Form 4 |
| Shizuru Judith Anne | director | Sep 22, 2025 | BUY | 41,000 | $2.92 | $119.7K | Form 4 |
| Brun Scott C. | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| EMSTER KURT VON | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| Shizuru Judith Anne | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| Nolet Chris | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| Kapoor Vishal | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| WIGGANS THOMAS G | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| Lucas Svetlana | director | Jul 3, 2025 | AWARD | 7,500 | $6.77 | $50.8K | Form 4 |
| MARTELL RON | director, officer: President and CEO | Jun 4, 2025 | AWARD | 234,000 | $6.00 | $1.4M | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Jun 4, 2025 | AWARD | 90,000 | $6.00 | $540.0K | Form 4 |
| CROSS HERB | Chief Financial Officer | Jun 4, 2025 | AWARD | 90,000 | $6.00 | $540.0K | Form 4 |
| Tucker Edwin Jonathan | Chief Medical Officer | Jun 4, 2025 | AWARD | 90,000 | $6.00 | $540.0K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Feb 13, 2025 | AWARD | 50,000 | $6.20 | $310.0K | Form 4 |
| MARTELL RON | director, officer: President, CEO and Director | Feb 13, 2025 | AWARD | 130,000 | $6.20 | $806.0K | Form 4 |
| CROSS HERB | Chief Financial Officer | Feb 13, 2025 | AWARD | 50,000 | $6.20 | $310.0K | Form 4 |
| Tucker Edwin Jonathan | Chief Medical Officer | Feb 13, 2025 | AWARD | 50,000 | $6.20 | $310.0K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Dec 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Dec 12, 2024 | SELL | 900 | $22.11 | $19.9K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Dec 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Sep 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Sep 12, 2024 | SELL | 900 | $21.23 | $19.1K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Sep 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Lucas Svetlana | director | Jun 18, 2024 | AWARD | 15,000 | $23.19 | $347.9K | Form 4 |
| Lucas Svetlana | director: | Jun 18, 2024 | OTHER | 0 | — | — | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Jun 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Jun 12, 2024 | SELL | 900 | $24.16 | $21.7K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Jun 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| MARTELL RON | director, officer: President, CEO and Director | Jun 10, 2024 | AWARD | 20,000 | — | — | Form 4 |
| MARTELL RON | director, officer: President, CEO and Director | Jun 10, 2024 | AWARD | 10,000 | $23.95 | $239.5K | Form 4 |
| Tucker Edwin Jonathan | Chief Medical Officer | Jun 7, 2024 | AWARD | 400 | $4.17 | $1.7K | Form 4 |
| French Anna Louise | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| Nolet Chris | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| Shizuru Judith Anne | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| Kapoor Vishal | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| WIGGANS THOMAS G | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| Brun Scott C. | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| EMSTER KURT VON | director | Jun 6, 2024 | AWARD | 7,500 | $25.41 | $190.6K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Mar 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Mar 12, 2024 | SELL | 900 | $26.44 | $23.8K | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Mar 12, 2024 | OPTION EX. | 900 | $7.10 | $6.4K | Form 4 |
| MARTELL RON | director, officer: President, CEO and Director | Feb 15, 2024 | AWARD | 100,000 | $17.95 | $1.8M | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Feb 15, 2024 | AWARD | 40,000 | $17.95 | $718.0K | Form 4 |
| CROSS HERB | Chief Financial Officer | Feb 15, 2024 | AWARD | 40,000 | $17.95 | $718.0K | Form 4 |
| Tucker Edwin Jonathan | Chief Medical Officer | Feb 15, 2024 | AWARD | 45,000 | $17.95 | $807.8K | Form 4 |
| Carlyle Group Inc. | other: Former 10% Owner | Feb 8, 2024 | BUY | 190,000 | $12.95 | $2.5M | Form 4 |
| Velan Capital Investment Management LP | 10 percent owner | Feb 8, 2024 | BUY | 350,000 | $12.95 | $4.5M | Form 4 |
| WIGGANS THOMAS G | director | Nov 28, 2023 | BUY | 10,000 | $0.65 | $6.5K | Form 4 |
| WIGGANS THOMAS G | director | Nov 21, 2023 | BUY | 10,000 | $0.64 | $6.4K | Form 4 |
| WIGGANS THOMAS G | director | Nov 20, 2023 | BUY | 10,000 | $0.63 | $6.3K | Form 4 |
| WIGGANS THOMAS G | director | Nov 17, 2023 | BUY | 10,000 | $0.60 | $6.0K | Form 4 |
| WIGGANS THOMAS G | director | Nov 16, 2023 | BUY | 10,000 | $0.60 | $6.0K | Form 4 |
| WIGGANS THOMAS G | director | Nov 1, 2023 | AWARD | 110,000 | $0.69 | $75.9K | Form 4 |
| WIGGANS THOMAS G | director: | Nov 1, 2023 | OTHER | 0 | — | — | Form 4 |
| Mahal Jeetinder Singh | Chief Operating Officer | Oct 12, 2023 | TAX W/H | 37,126 | $0.85 | $31.6K | Form 4 |
| MARTELL RON | director, officer: President, CEO & Director | Oct 12, 2023 | TAX W/H | 87,531 | $0.85 | $74.4K | Form 4 |
| Lis William | director | Oct 13, 2023 | SELL | 7,965 | $0.85 | $6.8K | Form 4 |
| CROSS HERB | Chief Financial Officer | Sep 22, 2023 | AWARD | 550,000 | $0.78 | $429.0K | Form 4 |
| CROSS HERB | officer | Sep 22, 2023 | OTHER | 0 | — | — | Form 4 |
| Brun Scott C. | director | Jun 20, 2023 | AWARD | 94,000 | $1.35 | $126.9K | Form 4 |
| Brun Scott C. | director: | Jun 20, 2023 | OTHER | 0 | — | — | Form 4 |
| Mahal Jeetinder Singh | See Remarks | Jun 13, 2023 | OPTION EX. | 9,000 | $0.71 | $6.4K | Form 4 |
| Mahal Jeetinder Singh | See Remarks | Jun 13, 2023 | SELL | 9,000 | $1.66 | $14.9K | Form 4 |
| Mahal Jeetinder Singh | See Remarks | Jun 13, 2023 | OPTION EX. | 9,000 | $0.71 | $6.4K | Form 4 |
| Tucker Edwin Jonathan | Chief Medical Officer | Jun 12, 2023 | AWARD | 400,000 | $1.62 | $648.0K | Form 4 |
| Tucker Edwin Jonathan | officer | Jun 12, 2023 | OTHER | 0 | — | — | Form 4 |
| Kapoor Vishal | director | Jun 7, 2023 | AWARD | 47,000 | $1.60 | $75.2K | Form 4 |
| Klein Lawrence Otto | director | Jun 7, 2023 | AWARD | 47,000 | $1.60 | $75.2K | Form 4 |